Malaria kills an estimated two million people annually.
Another 200 million people are debilitated by recurrent attacks. Using new genetic technologies, scientists are developing vaccines designed to enable the body's immune system to recognize DNA sequences specific to the various malaria parasites. 55 persons, including physicians, scientists, lawyers, social scientists, public health administrators, and philosophers attended. Fifteen African countries, including South Africa, Zimbabwe and the Sudan, and six non-African nations, including Spain, Norway and the US, were represented at the seminar. Patents, authorship, money and medical benefits all flow towards the Northern countries.